APA (7th ed.) Citation

Slifstein, M., Qu, W., Gil, R., Weinstein, J. J., Perlman, G., Jaworski-Calara, T., . . . Abi-Dargham, A. (2024). Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia. Neuropsychopharmacology: At the intersection of brain, behavior, and therapeutics, 49(13), 2087. https://doi.org/10.1038/s41386-024-01975-3

Chicago Style (17th ed.) Citation

Slifstein, Mark, et al. "Kappa Opioid Receptor Availability Predicts Severity of Anhedonia in Schizophrenia." Neuropsychopharmacology: At the Intersection of Brain, Behavior, and Therapeutics 49, no. 13 (2024): 2087. https://doi.org/10.1038/s41386-024-01975-3.

MLA (9th ed.) Citation

Slifstein, Mark, et al. "Kappa Opioid Receptor Availability Predicts Severity of Anhedonia in Schizophrenia." Neuropsychopharmacology: At the Intersection of Brain, Behavior, and Therapeutics, vol. 49, no. 13, 2024, p. 2087, https://doi.org/10.1038/s41386-024-01975-3.